306 related articles for article (PubMed ID: 28207201)
1. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.
Saab J; Hoda RS; Narula N; Hoda SA; Geraghty BE; Nasar A; Alperstein SA; Port JL; Giorgadze T
Cancer Cytopathol; 2017 Feb; 125(2):128-137. PubMed ID: 28207201
[TBL] [Abstract][Full Text] [Related]
2. Pericardial fluid cytology: an analysis of 128 specimens over a 6-year period.
Dragoescu EA; Liu L
Cancer Cytopathol; 2013 May; 121(5):242-51. PubMed ID: 23362233
[TBL] [Abstract][Full Text] [Related]
3. A Minimum Volume of More Than 60 mL Is Necessary for Adequate Cytologic Diagnosis of Malignant Pericardial Effusions.
Rooper LM; Ali SZ; Olson MT
Am J Clin Pathol; 2016 Jan; 145(1):101-6. PubMed ID: 26712877
[TBL] [Abstract][Full Text] [Related]
4. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
[TBL] [Abstract][Full Text] [Related]
5. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract][Full Text] [Related]
6. Cytomorphological profile of neoplastic effusions: an audit of 10 years with emphasis on uncommonly encountered malignancies.
Gupta S; Sodhani P; Jain S
J Cancer Res Ther; 2012; 8(4):602-9. PubMed ID: 23361282
[TBL] [Abstract][Full Text] [Related]
7. Cytopathologic analysis of pericardial effusions in 116 cases: Implications for poor prognosis in lung cancer patients with positive interpretations.
He B; Yang Z; Zhao P; Li YJ; Wang JG
Diagn Cytopathol; 2017 Apr; 45(4):287-293. PubMed ID: 28139896
[TBL] [Abstract][Full Text] [Related]
8. Secondary pericardial malignancies: a critical appraisal of the role of cytology, pericardial biopsy, and DNA ploidy analysis.
Bardales RH; Stanley MW; Schaefer RF; Liblit RL; Owens RB; Surhland MJ
Am J Clin Pathol; 1996 Jul; 106(1):29-34. PubMed ID: 8701928
[TBL] [Abstract][Full Text] [Related]
9. Malignancies in Pleural, Peritoneal, and Pericardial Effusions.
Dermawan JKT; Policarpio-Nicolas ML
Arch Pathol Lab Med; 2020 Sep; 144(9):1086-1091. PubMed ID: 31913661
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of malignant pericarditis: a single centre experience.
Pawlak Cieślik A; Szturmowicz M; Fijałkowska A; Gątarek J; Gralec R; Błasińska-Przerwa K; Szczepulska-Wójcik E; Skoczylas A; Bilska A; Tomkowski W
Kardiol Pol; 2012; 70(11):1147-53. PubMed ID: 23180523
[TBL] [Abstract][Full Text] [Related]
11. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
12. Cytologic detection of malignancy in pleural effusion: a review of 5,255 samples from 3,811 patients.
Hsu C
Diagn Cytopathol; 1987 Mar; 3(1):8-12. PubMed ID: 3568976
[TBL] [Abstract][Full Text] [Related]
13. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
[TBL] [Abstract][Full Text] [Related]
14. Symptomatic pericardial effusion in breast cancer patients: the role of fluid cytology.
Edoute Y; Kuten A; Ben-Haim SA; Moscovitz M; Malberger E
J Surg Oncol; 1990 Dec; 45(4):265-9. PubMed ID: 2250477
[TBL] [Abstract][Full Text] [Related]
15. Cytology of Pericardial Effusion due to Malignancy.
Kalogeraki A; Lazopoulos G; Papadakis GZ; Tamiolakis D; Karvela-Kalogeraki I; Karvelas-Kalogerakis M; Segredakis J; Chalkiadakis GE
Rom J Intern Med; 2016 Sep; 54(3):179-183. PubMed ID: 27658166
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and categorization of malignant effusions: A 6-year review from a single academic institution.
Lew M; Cantley R; Heider A; Jing X
Diagn Cytopathol; 2021 May; 49(5):615-621. PubMed ID: 32275354
[TBL] [Abstract][Full Text] [Related]
17. Clinico-cytopathologic analysis of 574 Pericardial Effusion Specimens: Application of the international system for reporting serous fluid cytopathology (ISRSFC) and long-term clinical follow-up.
Song MJ; Jo U; Jeong JS; Cho KJ; Gong G; Cho YM; Song JS
Cancer Med; 2021 Dec; 10(24):8899-8908. PubMed ID: 34747147
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of immunohistochemistry staining and cytologic diagnosis by using cell block sections prepared with effusion fluid cytology specimens].
Mao YY; Yang M; Liu DG; Lin MH; Zhang LQ; Chen ZQ
Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):547-50. PubMed ID: 20021967
[TBL] [Abstract][Full Text] [Related]
19. Etiology and Long-Term Outcome of Patients Undergoing Pericardiocentesis.
Strobbe A; Adriaenssens T; Bennett J; Dubois C; Desmet W; McCutcheon K; Van Cleemput J; Sinnaeve PR
J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29275375
[TBL] [Abstract][Full Text] [Related]
20. Malignant pericardial effusion.
García-Riego A; Cuiñas C; Vilanova JJ
Acta Cytol; 2001; 45(4):561-6. PubMed ID: 11480719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
